NCT03921671 2024-05-29
RELEVENT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
Clinical Trials
16 trialsNCT05455840 2023-10-31
A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease
Chang Gung Memorial Hospital
Phase NA Unknown
NCT06086327 2023-10-17
Application of 68Ga-Pentixafor PET/CT for Thymoma
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT06019468 2023-09-06
Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Unknown
NCT06010277 2023-08-24
FLEX
Amphia Hospital
Phase 4 Unknown
NCT03134118 2023-02-21
NIVOTHYM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown
NCT05407649 2022-06-07
Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours
Shanghai Cancer Hospital, China
Phase 2 Unknown
NCT05262582 2022-05-24
RATS
Shanghai Pulmonary Hospital, Shanghai, China
Phase NA Unknown
NCT03663764 2021-12-10
Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor
Sun Yat-sen University
Phase 2 Unknown
NCT03449173 2021-06-09
Style
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT03613272 2021-05-07
The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum
Tongji University
Phase NA Unknown
NCT04554524 2020-10-28
Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma
Tang-Du Hospital
Phase 4 Unknown
NCT02014805 2020-07-16
Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma
ChineseAMS
Phase 3 Unknown
NCT02364076 2019-12-13
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
Phase 2 Unknown
NCT03466827 2018-03-15
TET-SEL
Rigshospitalet, Denmark
Phase 2 Unknown
NCT01242072 2012-07-18
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
Alaunos Therapeutics
Phase 1 Unknown